Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2025-08-20 00:00:00 ET · period of report 2025-08-18 · accession 0001415889-25-022442 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-20 | 2025-08-18 | STOK | Ticho Barry | Chief MEDICAL Off | S - Sale | $18.24 | -2,805 | 24.0K | -10% | -$51.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-18 | S | D | 2,805 | $18.24 | 23,970 | D | — | — | (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.50 per share, inclusive. |